Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-065954
Filing Date
2017-12-15
Accepted
2017-12-15 16:38:09
Documents
2
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10786
2 POA DOCUMENT poa.txt EX-24.4_757252 3527
  Complete submission text file 0001209191-17-065954.txt   15700
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES 1601 TRAPELO ROAD, SUITE 286 WALTHAM MA 02451
Business Address
Race Geoff (Reporting) CIK: 0001610382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 171259475